Powered by lexis nexis

Concert Pharmaceuticals Reports First Quarter 2017 Financial Results

May 02, 2017 - Business Wire

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2017.

"We expect to significantly strengthen our cash position in 2017 through the asset purchase agreement that we entered into with Vertex Pharmaceuticals for the sale of CTP-656 and other cystic fibrosis assets," said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals. "Pending the closing of the Vertex transaction, we will be well positioned to advance...